Market Cap | ₹798Cr |
ROE | 6.13% |
P/E Ratio(TTM) | 40.37 |
EPS(TTM) | 8.88 |
P/B Ratio | 2.71 |
Dividend Yield | 0.00% |
Industry P/E | 35.07 |
Book Value | 132.19 |
Debt to Equity | 0.26 |
Face Value | 10 |
Parent Organisation | Sakar Healthcare |
Managing Director | Mr. Aarsh Shah |
NSE Symbol | SAKAR |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 105.21 | ||
Emcure Pharmaceuticals | NA (0.00%) | 34.98 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.27 | ||
Wockhardt | NA (0.00%) | -154.77 |